Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06267_nanopub.RAwKH1EX5Gpa2gEtsVW9J6-Y-zYXn5xE_DrR2bBLHqRB0#assertion>. }
Showing items 1 to 18 of
18
with 100 items per page.
- drugbank:DB06267 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06267 label "Udenafil [drugbank:DB06267]" assertion.
- drugbank:DB06267 seeAlso DB06267 assertion.
- drugbank:DB06267 identifier "drugbank:DB06267" assertion.
- drugbank:DB06267 description "Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada." assertion.
- drugbank:DB06267 title "Udenafil" assertion.
- drugbank:DB06267 bio2rdf_vocabulary:identifier "DB06267" assertion.
- drugbank:DB06267 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06267 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06267" assertion.
- drugbank:DB06267 bio2rdf_vocabulary:x-identifiers.org DB06267 assertion.
- drugbank:DB06267 drugbank_vocabulary:drugbank-id "DB06267" assertion.
- drugbank:DB06267 drugbank_vocabulary:x-cas cas:268203-93-6 assertion.
- drugbank:DB06267 drugbank_vocabulary:x-chemspider chemspider:5293720 assertion.
- drugbank:DB06267 drugbank_vocabulary:x-pubchemcompound pubchem.compound:6918523 assertion.
- drugbank:DB06267 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:99443240 assertion.
- drugbank:DB06267 drugbank_vocabulary:x-kegg kegg:D10027 assertion.
- drugbank:DB06267 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164776753 assertion.
- drugbank:DB06267 drugbank_vocabulary:x-wikipedia wikipedia:Udenafil assertion.